Epidemiology and surveillance for hepatocellular carcinoma: New trends

AG Singal, P Lampertico, P Nahon - Journal of hepatology, 2020 - Elsevier
The burden of hepatocellular carcinoma (HCC) is highest in East Asia and Africa, although
its incidence and mortality are rapidly rising in the United States and Europe. With the …

NAFLD-associated HCC: progress and opportunities

D Geh, QM Anstee, HL Reeves - Journal of Hepatocellular …, 2021 - Taylor & Francis
Due to an increase in the obesity-associated metabolic syndrome of epidemic proportions,
nonalcoholic fatty liver disease (NAFLD) is becoming a leading cause of hepatocellular …

Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study

M Stepien, P Keski‐Rahkonen, A Kiss… - … journal of cancer, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) development entails changes in liver metabolism. Current
knowledge on metabolic perturbations in HCC is derived mostly from case‐control designs …

[HTML][HTML] Diagnostic performance of AFP, AFP-L3, or PIVKA-II for hepatitis C virus-associated hepatocellular carcinoma: a multicenter analysis

S Liu, L Sun, L Yao, H Zhu, Y Diao, M Wang… - Journal of Clinical …, 2022 - mdpi.com
Background and Aim: Alpha-fetoprotein (AFP), a lens culinaris agglutinin-reactive fraction of
AFP (AFP-L3), is a protein that is induced by vitamin K deficiency or antagonist-II (PIVKA-II) …

Hepatocellular carcinoma in non-alcoholic fatty liver disease—A review of an emerging challenge facing clinicians

D Geh, DM Manas, HL Reeves - Hepatobiliary surgery and …, 2021 - pmc.ncbi.nlm.nih.gov
Importance Non-alcoholic fatty liver disease (NAFLD) is a rapidly growing cause of chronic
liver disease and is becoming a leading cause of hepatocellular carcinoma (HCC) in many …

COVID-19 and liver cancer: lost patients and larger tumours

D Geh, R Watson, G Sen, JJ French… - BMJ Open …, 2022 - bmjopengastro.bmj.com
Background Northern England has been experiencing a persistent rise in the number of
primary liver cancers, largely driven by an increasing incidence of hepatocellular carcinoma …

Hepatic outcomes of nonalcoholic fatty liver disease including cirrhosis and hepatocellular carcinoma

SA Alqahtani, WK Chan, ML Yu - Clinics in liver disease, 2023 - liver.theclinics.com
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver
diseases in developed countries, and its prevalence and incidence are rapidly increasing …

A tale of two complications of obesity: NASH and hepatocellular carcinoma

R Dhanasekaran, DW Felsher - Hepatology, 2019 - journals.lww.com
Potential conflict of interest: Dr. Hopkin consults for, advises for, is on the speakers' bureau
for, and received grants from Sanofi Genzyme and Alexion. He consults for, advises for, and …

[HTML][HTML] NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden

D Georgescu, DF Lighezan, CI Rosca, D Nistor… - Life, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most frequently found primary malignancy of the
liver, showing an accelerated upward trend over the past few years and exhibiting an …

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity

SM Samarasinghe, AS Hewage… - Egyptian Journal of …, 2023 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver
disease showing a rising prevalence globally. Genetic predisposition plays a key role in the …